NCT05865301 2026-02-09
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
Stanford University
Recruiting
Clinical Trials
9 trialsNCT04472286 2024-08-30
HBHL
University of Nebraska
Completed
NCT06075212 2023-10-10
Immune Reconstitution After Allo-HSCT and Blinatumomab
Sichuan University
Unknown
NCT02434484 2021-01-26
Symbenda Post-Marketing Surveillance (PMS)
Eisai Inc.
Completed
NCT00339664 2020-03-30
Analyses of Human Samples Collected in Clinical Trials
National Institutes of Health Clinical Center (CC)
Completed
NCT02885038 2017-10-02
TCP
Etablissement Français du Sang
Completed
NCT01144793 2016-12-28
Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias
Stanford University
Completed
NCT02461316 2016-11-02
Rituximab in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia
Hoffmann-La Roche
Completed
NCT00315419 2010-04-21
Identifying Characteristics of Bone Marrow Failure Syndromes
Office of Rare Diseases (ORD)
Unknown